Type of vascular invasion in association with progress of endometrial cancer. Issue 12 (4th October 2017)

• Record Type: Journal Article
• Authors: Visser, Nicole C.M.; Werner, Henrica M.J.; Krakstad, Camilla; Mauland, Karen K.; Trovik, Jone; Massuger, Leon F.A.G.; Nagtegaal, Iris D.; Pijnenborg, Johanna M.A.; Salvesen, Helga B.; Bulten, Johan; Stefansson, Ingunn M.
• Is Part Of: Apmis. Volume 125:Issue 12(2017:Dec.)
• Page Start: 1084
• Page End: 1091
• Publication Date: 2017-10-04
• Subjects: Endometrial cancer -- vascular invasion -- immunohistochemistry -- lymph node metastasis -- distant metastasis; Pathology -- Periodicals; Microbiology -- Periodicals; Immunology -- Periodicals; 572
• DOI: 10.1111/apm.12774
• Languages: English
• ISSNs: 0903-4641

Abstract

Abstract : Vascular invasion (VI) is a well‐established marker for lymph node metastasis and outcome in endometrial cancer. Our study explored whether specific types of VI, defined as lymphatic (LVI) or blood vessel invasion (BVI), predict pattern of metastasis. From a prospectively collected cohort, we conducted a case–control study by selecting three groups of endometrial cancer patients (n = 183): 52 with positive lymph nodes at primary surgery, 33 with negative nodes at primary surgery and later recurrence and death from disease, and 98 with negative nodes and no recurrence. All patients underwent hysterectomy with lymphadenectomy. Immunohistochemical staining with D2‐40 and CD31 antibodies was used to differentiate between BVI and LVI. By immunohistochemical staining, detection of VI increased from 24.6 to 36.1% of the cases. LVSI was significantly more often seen in patients with positive lymph nodes compared with patients with negative nodes (p = 0.001). BVI was significantly more often seen in node‐negative patients with recurrence compared with node‐negative patients without recurrence (p = 0.011). In multivariable analysis, BVI, age, and tumor grade were predictors separating patients with and without recurrence. Lymph node–positive patients showed more often LVI compared with lymph node–negative patients, while BVI seems to be a predictor for recurrent disease.